申请人:Janssen Pharmaceutica N.V.
公开号:US08252935B2
公开(公告)日:2012-08-28
The present invention relates to compounds of Formula I as shown below, wherein the definitions of Het, R0, R1 R2, R3, R4, R5, R6, R7, R8, and R9 are provided in the specification. Compounds of Formula I are useful for the treatment of diseases associated with γ-secretase activity, including Alzheimer's disease.
本发明涉及如下式I的化合物,其中Het、R0、R1、R2、R3、R4、R5、R6、R7、R8和R9的定义在说明书中提供。式I的化合物对于治疗与γ-分泌酶活性相关的疾病,包括阿尔茨海默病是有用的。